AUTHOR: Biomed Mom TITLE: Copper imbalance DATE: 6/29/2007 05:40:00 AM ----- BODY:
Proper Name: Copper Common Name: Copper Evidence of Efficacy: statement to the effect of Copper deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between copper and ADHD1,2,3, depression4,5,6, premenstrual syndrome7, and schizophrenia8,9,10,11,12,13,14,15,16,17,18,19,20. References: 1. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. [Deficiency of certain trace elements in children with hyperactivity.] Psychiatr Pol 28(3):345-53, 1994. 2. Brenner A. Trace mineral levels in hyperactive children responding to the Feingold diet. J Pediatr 94 (60):944-5, 1979. 3. Pfeiffer CC, Mailloux R. Excess copper as a factor in human diseases. J Orthomol Med 2(3):171-82, 1987. 4. Hansen Cr Jr et al. Copper and zinc deficiencies in association with depression and neurological findings. Biol Psychiatry 18(3):395-401, 1983. 5. Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35(4):272-4, 1991. 6. Ali SA et al. Blood levels of vanadium, caesium, and other elements in depressive patients. J Affect Disord 9:187-91, 1985. 7. Choung C, Dawson E. Zinc and copper levels in premenstrual syndrome. Fert Steril 62:313-20, 1994. 8. Kornhuber J, Lange KW, Kruzik P, et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients. Biol Psychiatry 36(1):31-4, 1994. 9. Shore D et al. CSF copper concentrations in chronic schizophrenia. Am J Psychiatry 140(6):754-7, 1983. 10. Tyrer SP et al. CSF copper in schizophrenia. Am J Psychiatry 136(7):937-9, 1979. 11. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 12. Olatunbosun DA at al. Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127:119-21, 1975. 13. Pfeiffer CC, Illiev V. A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Biol Suppl 1, 1972. 14. Heilmeyer L, Keiderling W, Struve C. Kupfer and eisen als. Korpereigene Wirkstoffe und Ihre Bedeutung Beim Krankheitgeschehen. Fischer, Jena, Germany, 1941. 15. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenias. J Orthomol Psychiatry 12:215-34, 1983. 16. Bowman MB, Lewis MS. The copper hypothesis of schizophrenia: a review. Neurosci Biobehav Rev 6:321-8, 1982. 17. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 18. Mattke JD, Adler M. Mode of action of D-penicillamine in chronic schizophrenia. Dis Nerv Sys 32:388, 1971. 19. Affleck JW et al., Penicillamine and schizophrenia – A clinical trial. Br J Psychiatry 115:173, 1969. 20. Nicholson GA et al. Effect of D-penicillamine on schizophrenic patients. Lancet i:344, 1966.

Labels: , , , , , ,

----- -------- /* ----------------------------------------------- Blogger Template Style Name: Son of Moto (Mean Green Blogging Machine variation) Designer: Jeffrey Zeldman URL: www.zeldman.com Date: 23 Feb 2004 ----------------------------------------------- */ /* Primary layout */ body { margin: 0; padding: 0; border: 0; text-align: center; color: #554; background: #692 url(http://www.blogblog.com/moto_son/outerwrap.gif) top center repeat-y; font: small tahoma, "Bitstream Vera Sans", "Trebuchet MS", "Lucida Grande", lucida, helvetica, sans-serif; } img { border: 0; display: block; } /* Wrapper */ @media all { #wrapper { margin: 0 auto; padding: 0; border: 0; width: 692px; text-align: left; background: #fff url(http://www.blogblog.com/moto_son/innerwrap.gif) top right repeat-y; font-size:90%; } } @media handheld { #wrapper { width: 90%; } } /* Header */ #blog-header { color: #ffe; background: #8b2 url(http://www.blogblog.com/moto_son/headbotborder.gif) bottom left repeat-x; margin: 0 auto; padding: 0 0 15px 0; border: 0; } #blog-header h1 { font-size: 24px; text-align: left; padding: 15px 20px 0 20px; margin: 0; background-image: url(http://www.blogblog.com/moto_son/topper.gif); background-repeat: repeat-x; background-position: top left; } #blog-header p { font-size: 110%; text-align: left; padding: 3px 20px 10px 20px; margin: 0; line-height:140%; } /* Inner layout */ #content { padding: 0 20px; } @media all { #main { width: 400px; float: left; } #sidebar { width: 226px; float: right; } } @media handheld { #main { width: 100%; float: none; } #sidebar { width: 100%; float: none; } } /* Bottom layout */ #footer { clear: left; margin: 0; padding: 0 20px; border: 0; text-align: left; border-top: 1px solid #f9f9f9; background-color: #fdfdfd; } #footer p { text-align: left; margin: 0; padding: 10px 0; font-size: x-small; background-color: transparent; color: #999; } /* Default links */ a:link, a:visited { font-weight : bold; text-decoration : none; color: #692; background: transparent; } a:hover { font-weight : bold; text-decoration : underline; color: #8b2; background: transparent; } a:active { font-weight : bold; text-decoration : none; color: #692; background: transparent; } /* Typography */ #main p, #sidebar p { line-height: 140%; margin-top: 5px; margin-bottom: 1em; } .post-body { line-height: 140%; } h2, h3, h4, h5 { margin: 25px 0 0 0; padding: 0; } h2 { font-size: large; } h3.post-title { margin-top: 5px; font-size: medium; } ul { margin: 0 0 25px 0; } li { line-height: 160%; } #sidebar ul { padding-left: 10px; padding-top: 3px; } #sidebar ul li { list-style: disc url(http://www.blogblog.com/moto_son/diamond.gif) inside; vertical-align: top; padding: 0; margin: 0; } dl.profile-datablock { margin: 3px 0 5px 0; } dl.profile-datablock dd { line-height: 140%; } .profile-img {display:inline;} .profile-img img { float:left; margin:0 10px 5px 0; border:4px solid #8b2; } #comments { border: 0; border-top: 1px dashed #eed; margin: 10px 0 0 0; padding: 0; } #comments h3 { margin-top: 10px; margin-bottom: -10px; font-weight: normal; font-style: italic; text-transform: uppercase; letter-spacing: 1px; } #comments dl dt { font-weight: bold; font-style: italic; margin-top: 35px; padding: 1px 0 0 18px; background: transparent url(http://www.blogblog.com/moto_son/commentbug.gif) top left no-repeat; color: #998; } #comments dl dd { padding: 0; margin: 0; } .deleted-comment { font-style:italic; color:gray; } /* Feeds ----------------------------------------------- */ #blogfeeds { } #postfeeds { }

Adopt Biomed

This blog gathers information about biomedical interventions for children with adoption trauma and Reactive Attachment Disorder. Posts are gathered from multiple websites in one place. Most posts contain unedited text relating to biomedical treatment, dietary changes, vitamins, homeopathy, herbs, etc. Where possible, the link to the original information is included.

Friday, June 29, 2007

Copper imbalance

Proper Name: Copper Common Name: Copper Evidence of Efficacy: statement to the effect of Copper deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between copper and ADHD1,2,3, depression4,5,6, premenstrual syndrome7, and schizophrenia8,9,10,11,12,13,14,15,16,17,18,19,20. References: 1. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. [Deficiency of certain trace elements in children with hyperactivity.] Psychiatr Pol 28(3):345-53, 1994. 2. Brenner A. Trace mineral levels in hyperactive children responding to the Feingold diet. J Pediatr 94 (60):944-5, 1979. 3. Pfeiffer CC, Mailloux R. Excess copper as a factor in human diseases. J Orthomol Med 2(3):171-82, 1987. 4. Hansen Cr Jr et al. Copper and zinc deficiencies in association with depression and neurological findings. Biol Psychiatry 18(3):395-401, 1983. 5. Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35(4):272-4, 1991. 6. Ali SA et al. Blood levels of vanadium, caesium, and other elements in depressive patients. J Affect Disord 9:187-91, 1985. 7. Choung C, Dawson E. Zinc and copper levels in premenstrual syndrome. Fert Steril 62:313-20, 1994. 8. Kornhuber J, Lange KW, Kruzik P, et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients. Biol Psychiatry 36(1):31-4, 1994. 9. Shore D et al. CSF copper concentrations in chronic schizophrenia. Am J Psychiatry 140(6):754-7, 1983. 10. Tyrer SP et al. CSF copper in schizophrenia. Am J Psychiatry 136(7):937-9, 1979. 11. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 12. Olatunbosun DA at al. Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127:119-21, 1975. 13. Pfeiffer CC, Illiev V. A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Biol Suppl 1, 1972. 14. Heilmeyer L, Keiderling W, Struve C. Kupfer and eisen als. Korpereigene Wirkstoffe und Ihre Bedeutung Beim Krankheitgeschehen. Fischer, Jena, Germany, 1941. 15. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenias. J Orthomol Psychiatry 12:215-34, 1983. 16. Bowman MB, Lewis MS. The copper hypothesis of schizophrenia: a review. Neurosci Biobehav Rev 6:321-8, 1982. 17. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 18. Mattke JD, Adler M. Mode of action of D-penicillamine in chronic schizophrenia. Dis Nerv Sys 32:388, 1971. 19. Affleck JW et al., Penicillamine and schizophrenia – A clinical trial. Br J Psychiatry 115:173, 1969. 20. Nicholson GA et al. Effect of D-penicillamine on schizophrenic patients. Lancet i:344, 1966.

Labels: , , , , , ,

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home